Overview
Compare peptides researched for soft-tissue healing, tendon or joint support, wound repair, and getting back to training sooner.
10 of 46 published compounds
$192.00
Tissue Repair & Recovery
injury recovery, joint support, soft-tissue repair, return-to-training
Goal hub next step
Build a recovery & injury support research path.
Use the quiz before choosing a compound, vendor, or PDF so the route reflects your goal, risk tolerance, and monitoring comfort.
Best options to research first
Ranked by evidence first, then risk. A research starting point, not a clinical recommendation.
Thymosin Beta-4
Actin-sequestering peptide with clinical data in ophthalmic wound healing and preclinical tissue repair.
topical, subcutaneous
Corneal healing studies: days to weeks; systemic repair claims are less well-timed.
$192.00
1 tracked
GHK-Cu
Copper peptide complex with substantial topical/cosmetic literature for skin and hair repair.
topical
Skin remodeling: weeks to months (collagen turnover cycles).
$60.00
3 tracked
LL-37
Human antimicrobial peptide with topical wound healing studies. Antimicrobial therapeutic claims trigger regulatory scrutiny.
topical
Wound endpoints measured over weeks.
0 tracked
Vasoactive Intestinal Peptide
Rapid-acting vasoactive neuropeptide with experimental use in pulmonary and immune settings.
subcutaneous, intravenous
Hemodynamic effects occur within minutes; sustained protocols are needed for longer exposure.
0 tracked
Cerebrolysin
Porcine neuropeptide mixture used in some international stroke and cognition programs, but not FDA-approved.
intravenous, intramuscular
Clinical outcomes are tracked over days to weeks in stroke or cognition programs.
0 tracked
Lower-risk options
Vasoactive Intestinal Peptide
Rapid-acting vasoactive neuropeptide with experimental use in pulmonary and immune settings.
Cerebrolysin
Porcine neuropeptide mixture used in some international stroke and cognition programs, but not FDA-approved.
Thymosin Beta-1
Less-studied thymosin-family peptide discussed for immune modulation with sparse human evidence.
Higher-risk options
Topical appears tolerable; systemic use carries different risk profile.
Limited data; growth-factor class concerns apply.
Trusted vendors for tissue-repair research
These vendors currently carry compounds in this goal category. Hub is the trust layer; outbound clicks happen after comparison.
Ignite Peptides
5 relevant compounds in hub
COA with order / verify current product report
third-party testing and COA documentation claimed by vendor; verify product-specific report
U.S. domestic territories only
affiliate: direct product page
Amino Club
4 relevant compounds in hub
product page COA viewer
third-party purity testing; product-level COA on page
US/ROW (verify current policy)
affiliate: public program
XL Peptides
4 relevant compounds in hub
testing reports on product page
third-party testing reports linked on product page
UK, Europe, and rest of world via vendor shipping options
affiliate: direct product page
Sources and review notes
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks - U.S. Food and Drug Administration - accessed 2026-05-15
Used for FDA compounding-risk context and peptide safety flags.
- The Prohibited List - World Anti-Doping Agency - accessed 2026-05-15
Used for athlete-facing WADA risk and peptide-class restrictions.
- Peptide therapeutics: current status and future directions - PubMed / Nature Reviews Drug Discovery - accessed 2026-05-15
Used for broad peptide-therapeutics background and evidence framing.